MyDx Inc. (fka MYDX)

[MightyX]

This is.the.beginning of.something.huge. I.was.hoping in my lifetime something like this would happen with MYDX and it could happen in 5 years or less!

Ok, months back(references to follow) I suggested how human Genomics are important because it is what MYDX has been saying all along, that each individual physiology is unique and so is how each physiology reacts to same cannabis strain. Phylos fits in perfect with the concept of cross referencing CannaDX sample test data with Phylos cannabis Genomics and now a feeling can be associated with a degree of accuracy to a specific cannabis genome, so now, the individual, not even knowing his/own gene sequence can identify with a specific cannabis plant for a specific ailment relief.

This cross-referencing of data makes each entity(Phylos and MYDX) codependent for generating even more meaningful data to offer the market place. This is the next step in the ultimate cost-effective human/cannabis genome project for medicinal purposes.

I’m not sure what he next step after this would be but eventually, hopefully in my lifetime as well MYDX will be involved in cross-referencing individual Genomics with cannabis Genomics where the individual would know with absolute certainty based on historical data what cannabis product to purchase to remedy a specific ailment or to provide a wanted reaction.

“Phylos uses genome sequencing technology to generate DNA “barcodes” that uniquely identify cannabis varieties. This information is important for basic scientific research, and it also serves as proof of existence that can be used to defend against attempts at patenting.”
http://www.phylosbioscience.com/about/data-policy/
Perhaps this can be used to fight of GW attempts at CBD patenting.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133208585
“Last year, the China Food and Drug Administration approved the sequencer as a medical device, allowing its use in clinical genetic testing...”

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132234994
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:

"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"

How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132627843
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?

MYDX major reasons why MYDX data is so valuable (followed by reference link):

"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."

"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."

"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX Why gAPI is so valuable (link reference to follow):

"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):

"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

Is HIPPA compliance important (reference link to follow)?

"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."

http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider

Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.